Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmaceutical Product Development (PPD), a global contract research organization that provides drug discovery, development and lifecycle management services, has reported net revenue of $407.7m for the second quarter ended 30 June 2011, an increase of 10.2% as compared to $369.92m for the same period in 2010.
Subscribe to our email newsletter
PPD‘s net income was $45.42m, compared to $20.98m for the same period in the prior year.
The company has posted operating income of $57.15m for the second quarter ended 30 June 2011, as compared to $40.08m for the same period in 2010.
For the six months ended 30 June 2011 total net revenue were $790.91m, compared to $716.69m for the same period in 2010.
Net income was $82.78m for the six months ended 30 June 2011, as compared to $38.18m for the same period prior year.
The company’s operating income for the six months ended 30 June 2011 was $109.6m, as compared to $67.77m for the same period in 2010.